Bioprospecting the antimicrobial, antibiofilm and antiproliferative activity of Symplocos racemosa Roxb. Bark phytoconstituents along with their biosafety evaluation and detection of antimicrobial components by GC-MS

Abstract Background Plants provide a ray of hope to combat the ever increasing antibiotic resistance and Symplocos racemosa is a valuable medicinal plant. The study focused on highlighting the importance of this plant's phytoconstituents as potential source of novel antimicrobials against plank...

Full description

Saved in:
Bibliographic Details
Main Authors: Henna Sood (Author), Yashwant Kumar (Author), Vipan Kumar Gupta (Author), Daljit Singh Arora (Author)
Format: Book
Published: BMC, 2020-11-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_01c4170bc32b4f6e871adb74e8f5d730
042 |a dc 
100 1 0 |a Henna Sood  |e author 
700 1 0 |a Yashwant Kumar  |e author 
700 1 0 |a Vipan Kumar Gupta  |e author 
700 1 0 |a Daljit Singh Arora  |e author 
245 0 0 |a Bioprospecting the antimicrobial, antibiofilm and antiproliferative activity of Symplocos racemosa Roxb. Bark phytoconstituents along with their biosafety evaluation and detection of antimicrobial components by GC-MS 
260 |b BMC,   |c 2020-11-01T00:00:00Z. 
500 |a 10.1186/s40360-020-00453-y 
500 |a 2050-6511 
520 |a Abstract Background Plants provide a ray of hope to combat the ever increasing antibiotic resistance and Symplocos racemosa is a valuable medicinal plant. The study focused on highlighting the importance of this plant's phytoconstituents as potential source of novel antimicrobials against planktonic as well as biofilm forming microorganisms, along with their antiproliferative activity. The biosafety of the phytoconstituents was also established, followed by detection of probable antimicrobial components. Methods The best organic extractant and major groups of phytoconstituents were tested for their antimicrobial activity against reference microbial strains and drug-resistant clinical isolates. The anti-proliferative potential of the most active group of phytoconstituents was evaluated against cancerous cell lines. The in vitro biosafety of phytoconstituents was evaluated by Ames and MTT assay, while in vivo biosafety of the most active phytoconstituents, i.e., flavonoids was determined by acute oral toxicity. Further, the probable antimicrobial components in the flavonoids were detected by TLC and GC-MS. Results Ethyl acetate extract was the most effective among various organic extracts, whereas phytoconstituents such as flavonoids, cardiac glycosides, saponins, tannins, triterpenes and phytosterols were the major groups present, with flavonoids being the most potent antimicrobials. The phytoconstituents displayed a significant antibiofilm potential, as exhibited by inhibition of initial cell attachment, disruption of the pre-formed biofilms and reduced metabolic activity of biofilms. The phytoconstituents were significantly active against the drug-resistant strains of E.coli, MRSA and Salmonella spp. Further, flavonoids showed significant cytotoxic effect against the cancerous cell lines but were non-cytotoxic against Vero (normal) cell line. All the test preparations were biosafe, as depicted by the Ames test and MTT assay. Also, flavonoids did not induce any abnormality in body weight, clinical signs, biochemical parameters and organs' histopathology of the Swiss albino mice during in vivo acute oral toxicity studies. The flavonoids were resolved into 4 bands (S1-S4), where S3 was the most active and its GC-MS analysis revealed the presence of a number of compounds, where Bicyclo [2.2.1]heptan-2-one,1,7,7-trimethyl-, (1S)- was the most abundant. Conclusions These findings suggest that the phytoconstituents from Symplocos racemosa bark could act as potential source of antimicrobial as well as antiproliferative metabolites. 
546 |a EN 
690 |a Antimicrobial 
690 |a Drug resistant strains 
690 |a Acute oral toxicity, Antibiofilm 
690 |a Cytotoxicity 
690 |a Symplocos racemosa 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
690 |a Toxicology. Poisons 
690 |a RA1190-1270 
655 7 |a article  |2 local 
786 0 |n BMC Pharmacology and Toxicology, Vol 21, Iss 1, Pp 1-20 (2020) 
787 0 |n http://link.springer.com/article/10.1186/s40360-020-00453-y 
787 0 |n https://doaj.org/toc/2050-6511 
856 4 1 |u https://doaj.org/article/01c4170bc32b4f6e871adb74e8f5d730  |z Connect to this object online.